VYGR
Voyager Therapeutics Inc
NASDAQ: VYGR · HEALTHCARE · BIOTECHNOLOGY
$3.73
+2.47% today
Updated 2026-04-30
Market cap
$224.69M
P/E ratio
—
P/S ratio
5.57x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$3 – $6
Volume
0.7M
Voyager Therapeutics Inc (VYGR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $17.33M | $14.22M | $10.13M | $7.62M | $104.39M | $171.13M | $37.41M | $40.91M | $250.01M | $80.00M | $40.37M |
| Revenue growth (YoY) | — | — | — | -18.0% | -28.7% | -24.8% | +1270.1% | +63.9% | -78.1% | +9.3% | +511.2% | -68.0% | -49.5% |
| Cost of revenue | $4.63M | $8.90M | $27.68M | $42.25M | $62.26M | $64.91M | $119.73M | $108.75M | $73.79M | $6.19M | $92.17M | $4.73M | $4.06M |
| Gross profit | $-4.63M | $-8.90M | $17.33M | $14.22M | $10.13M | $7.62M | $104.39M | $62.38M | $37.41M | $40.91M | $157.84M | $80.00M | $40.37M |
| Gross margin | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 36.4% | 100.0% | 100.0% | 63.1% | 100.0% | 100.0% |
| R&D | $4.63M | $8.90M | $27.68M | $42.25M | $62.26M | $64.91M | $119.73M | $108.75M | $73.79M | $60.76M | $92.17M | $127.37M | $134.67M |
| SG&A | $2.90M | $5.47M | $9.91M | $13.27M | $19.74M | $33.81M | $36.34M | $34.99M | $37.25M | $30.98M | $35.82M | $35.92M | $37.54M |
| Operating income | $-7.53M | $-14.37M | $-20.25M | $-41.30M | $-71.86M | $-91.09M | $-51.68M | $27.38M | $-73.62M | $-50.84M | $122.01M | $-83.29M | $-131.84M |
| Operating margin | — | — | -116.8% | -290.4% | -709.1% | -1195.6% | -49.5% | 16.0% | -196.8% | -124.3% | 48.8% | -104.1% | -326.6% |
| EBITDA | $-134000.00 | $-14.18M | $-19.65M | $-40.69M | $-70.27M | $-88.98M | $-48.91M | $31.20M | $-68.45M | $-44.65M | $126.45M | $-78.56M | $-127.78M |
| EBITDA margin | — | — | -113.4% | -286.1% | -693.3% | -1167.8% | -46.9% | 18.2% | -183.0% | -109.1% | 50.6% | -98.2% | -316.5% |
| EBIT | $-7.67M | $-14.37M | $-20.25M | $-41.30M | $-71.86M | $-91.09M | $-51.68M | $27.38M | $-73.62M | $-50.84M | $122.01M | $-83.29M | $-131.84M |
| Interest expense | — | $0.00 | $332000.00 | $976000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $390000.00 | $1.79M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.67M | $-16.32M | $-29.67M | $-40.19M | $-70.70M | $-88.29M | $-40.83M | $36.74M | $-66.03M | $-46.41M | $132.33M | $-65.00M | $-119.72M |
| Net income growth (YoY) | — | -112.8% | -81.8% | -35.5% | -75.9% | -24.9% | +53.8% | +190.0% | -279.7% | +29.7% | +385.1% | -149.1% | -84.2% |
| Profit margin | — | — | -171.2% | -282.7% | -697.6% | -1158.8% | -39.1% | 21.5% | -176.5% | -113.4% | 52.9% | -81.3% | -296.5% |